Increased plasma concentrations of serum amyloid A: An indicator of the acute-phase response after cardiopulmonary bypass

Critical Care Medicine

Volumn 25, Issue 9, 1997, Pages 1527-1533

  Berendes, Elmar ^a,c   Möllhoff, Thomas ^a   Van Aken, Hugo ^a   Erren, Michael ^b   Deng, Mario C ^c   Loick, Heinz Michael ^a  

^a Department of Anesthesiology and Surgical Intensive Care Medicine ^*

^b Leibniz Institute of Atherosclerosis Research   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Acute phase proteins; C reactive protein; Cardiopulmonary bypass; Endotoxemia; Intensive care unit; Interleukin 6; Serum amyloid A; Systemic inflammation

Indexed keywords

ADRENALIN; AMYLOID A PROTEIN; C REACTIVE PROTEIN; ENDOTOXIN; INTERLEUKIN 6; LACTIC ACID; OXYGEN;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HEMODYNAMICS; HUMAN; LIMULUS LYSATE TEST; MALE; NEPHELOMETRY; OXYGEN SATURATION; PLASMA; PRIORITY JOURNAL;

ACUTE-PHASE REACTION; AGED; APOLIPOPROTEINS; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; ENDOTOXINS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID A PROTEIN; SPLANCHNIC CIRCULATION; TIME FACTORS;

EID: 0030864582     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199709000-00020     Document Type: Article

References (39)

1. Livelli FD, Johnson RA, McEnany MT, et al: Unexplained in-hospital fever following cardiac surgery: Natural history, relationship to postpericardiotomy syndrome, and a prospective study of therapy with indomethacin versus placebo. Circulation 1978; 57:968-975
2. Miholic J, Hiertz H, Hudec M, et al: Fever, leukocytosis and infection after open heart surgery. A log-linear regression analysis of 115 cases. Thorac Cardiovasc Surg 1984; 32:45-48
3. Rocke DA, Gaffin SL, Wells MT, et al: Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987; 93:832-837
4. Nilsson L, Kulander L, Nystrom S, et al: Endotoxins in cardiopulmonary by-pass. J Thorac Cardiovasc Surg 1990; 100:777-780
5. Deng MC, Wiedner M, Erren M, et al: Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg 1995; 9:22-29
6. Ohri SK, Bjarnason I, Pathi V, et al: Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg 1993; 55:1080-1086
7. Taylor KM, Bain WH, Morton JJ: The role of angiotensin II in the development of peripheral vasoconstriction during open-heart surgery. Am Heart J 1980; 100:935-937
8. Chenoweth DE, Cooper SW, Hugli TE, et al: Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-503
9. Videm V, Fosse E, Mollnes TE, et al: Complement activation with bubble and membrane oxygenators in aortocoronary bypass grafting. Ann Thorac Surg 1990; 50:387-391
10. 2 levels during cardiopulmonary bypass. Circulation 1980; 61:808-814
11. Malle E, Steinmetz A, Raynes JG: Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 1993; 102:131-146
12. McAdam KP, Elin RJ, Sipe JD, et al: Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest 1978; 61:390-394
13. Ganapathi MK, Schultz D, Mackiewicz A, et al: Heterogeneous nature of the acute phase response: Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells. J Immunol 1988; 141:564-569
14. Husby G, Natvig JB: A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest 1974; 53:1054-1061
15. De Beer FC, Fagan EA, Hughes GRV, et al: Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 1982; ii:231-233
16. Shainkin-Kestenbaum R, Winikoff Y, Cristal N: Serum amyloid A concentrations during the course of acute ischemic heart disease. J Clin Pathol 1986; 39:635-637
17. Shainkin-Kestenbaum R, Zimlichman S, Winikoff Y, et al: Serum amyloid A (SAA) in viral infection: Rubella, measles and subacute sclerosing panencephalitis (SSPE). Clin Exp Immunol 1982; 50:503-506
18. Müller T, Schindler S, Sprenger H, et al: Prospective analysis of 10 different parameters of acute renal allograft rejection. Transplant Proc 1992; 24: 2731-2734
19. Lalli E, Meliconi R, Conte R, et al: Serum markers of immune activation and liver allograft rejection. Dig Dis Sci 1992; 37:1116-1120
20. Bausserman LL, Sadaniantz A, Saritelli AL, et al: Time course of serum amyloid A response in myocardial infarction. Clin Chim Acta 1989; 184:297-305
21. Liuzzo G, Biasucci LM, Gallimore JR, et al: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424
22. Selinger MJ, McAdam KP, Kaplan MM, et al: Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Nature 1980; 285:498-500
23. Nakayama T, Sonoda S, Urano T, et al: Monitoring both serum amyloid A protein and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem 1993; 39:293-297
24. Bausserman LL, Herbert PN, McAdam KP: Heterogeneity of human serum amyloid A proteins. J Exp Med 1980; 152:641-656
25. Kisilevsky R, Subrahmanyan L: Serum amyloid A changes high density lipoprotein's cellular affinity: A clue to serum amyloid A's principal function. Lab Invest 1992; 66:778-785
26. Brinkmann A, Wolf CF, Berger D, et al: Perioperative endotoxemia and bacterial translocation during major abdominal surgery: Evidence for the protective effect of endogenous prostacyclin? Crit Care Med 1996; 24:1293-1301
27. Kato M, Honda I, Suzuki H, et al: Production of interleukin-10 during and after upper abdominal surgery. Abstr. Anesthesiology 1996; 85:A146
28. Cruickshank AM, Fraser WD, Burns HJG, et al: Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 1990; 79:161-165
29. Jirik FR, Podor TJ, Hirano T, et al: Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989; 142:144-147
30. Moshage HJ, Roelofs HMJ, van Pelt JF, et al: The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult hepatocytes. Biochem Biophys Res Commun 1988; 155: 112-117
31. Finkel MS, Hoffmann RA, Shen L, et al: Interleukin-6 (IL-6) as a mediator of stunned myocardium. Am J Cardiol 1993; 71:1231-1232
32. Hattler BG, Garesan J 3rd, Shah N, et al: A potential role for nitric oxide in myocardial stunning. J Card Surg 1994; 9:425-429
33. Ohri SK, Bowles CT, Siddiqui A, et al: The effect of cardiopulmonary bypass on gastric and colonic mucosal perfusion: A tonometric assessment. Perfusion 1994; 9:101-108
34. Nagano K, Gelman S, Parks DA, et al: Hepatic oxygen supply-uptake relationship and metabolism during anesthesia in miniature pigs. Anesthesiology 1982; 37:548-553
35. Anderson LW, Landow L, Baek L, et al: Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-α concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 1993; 21: 210-217
36. 3 is a high density apolipo-protein and is secreted by macrophages. Proc Natl Acad Sci USA 1992; 89:7949-7952
37. Tape C, Kisilevsky R: Apolipoprotein A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis. Biochim Biophys Acta 1990; 1043:295-300
38. Colman RW: Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 1990; 49:323-324
39. Menasche P, Haydar S, Peynet J, et al: A potential mechanism of vasodilatation after heart surgery. The temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 1994; 107: 293-299